BCX-34: Began a Phase II trial

BioCryst Pharmaceuticals Inc. (BCRX), Birmingham, Ala. Product: BCX-34 small molecule inhibitor of an enzyme, purine nucleoside phosphorylase, involved in T cell proliferation Indication: Cutaneous T...